Atlas Trials

Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients

Clinical trial NCT04341207 · UNKNOWN

Trial details

NCT number
NCT04341207
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer & COVID 19
Start date
2020-04-03
Primary completion
2022-04-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.